Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants.
Woldesellassie M BezabheLuke R BereznickiJan RadfordBarbara C WimmerMohammed Saji SalahudeenIvan BindoffGregory M PetersonPublished in: Expert review of clinical pharmacology (2022)
The risk of renal function decline appeared to be lower in patients prescribed DOACs versus warfarin.